European Medicines Agency Jeopardizes Investments in Drug Development
Jones Day
December 28, 2012
4 pages
Thursday, May 23rd
Last update08:21:25 PM
Just in....
Font Size
Profile
Layout
Direction
Menu Style
You are here:
Country/Region 
European Union EU Pharma, Life Sciences & Health Pharmaceutical & Health Jones Day: European Medicines Agency Jeopardizes Investments in Drug Development
European Union EU Pharma, Life Sciences & Health Pharmaceutical & Health Jones Day: European Medicines Agency Jeopardizes Investments in Drug Development
Trending ..... Cybersecurity Proposals ..... ESMA's AIFMD Remuneration Guidance ..... Financial Transactions Tax ..... Model Leniency Program ..... EU Nearer to European Banking Union ..... UsedSoft: CJEU OKs sale of Used Software Licenses ..... The Eurozone Crisis ..... ESMA Consults on Prospectus Directive ..... New Round(s) of Iran Sanctions ..... Apple & E-publishing Giants Under Competition Microscope ..... EC Refreshes Bank State Aid Rules ..... Reform of Data Protection Directive ..... MiFID II ..... EU's MAD Proposal ..... A European Patent? Patent Court? ..... US & EU Sanctions Get Syria-ous ..... Solvency II
Latest News For Pharma & Life Sciences Sectors
Skadden: French Autorité de la Concurrence Fines Sanofi €40.6 Million for Denigrating Competing Generics
May 21, 2013
Pharmaceutical & Health
Arnold & Porter: Interim relief granted in challenge to EMA’s decision to disclose pre-clinical and clinical information from an application for a centralised marketing authorisation
May 07, 2013
Pharmaceutical & Health
-
-
-
-
-
-
K&L Gates: New EU Guidance on Health Claims
February 14, 2013 Pharmaceutical & Health -
-
Ashurst: Life sciences and regulatory newsletter
January 22, 2013 Pharmaceutical & Health -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
SJBerwin: Life Sciences & Healthcare Update
October 12, 2012 Pharmaceutical & Health -
-
Taylor Wessing: Medical devices - EU proposals announced
September 27, 2012 Pharmaceutical & Health -
-
-
-
-
-
-
-
-
-
EU Menu
 |
|
 |
 |